跳至主要内容
临床试验/IRCT20230930059563N1
IRCT20230930059563N1招募中2 期

Investigating of the adjuvant effect of melatonin in the prevention of preeclampsia in moderate and high risk women

Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
Female

入选标准

  • 16 years and older
  • 12-28 weeks of pregnancy
  • moderate to high risk of preeclampsia based on US Preventive Services Task Force criteria
  • informed consent

排除标准

  • Multiple pregnancy
  • Current or previous use of melatonin in the past 6 weeks
  • Allergy to melatonin and aspirin
  • Use of any of the following drugs that can interfere with the metabolism and/or elimination of melatonin: fluvoxamine, 5- or 8-methoxypsoralen, cimetidine, quinolones, and other CYP1A2 inhibitors. Carbamazepine, rifampicin and other CYP1A2 inducers. and zalplon, zolpidem, zopiclone, and other non-benzodiazepine hypnotics.
  • lose to follow-up
  • non cooperate
  • The presence of any disease or condition that is a contraindication for continued pregnancy
  • Fetal anomaly

研究者

相似试验